Order Article Reprints

Plested JS, Zhu M, Cloney-Clark S, Massuda E, Patel U, Klindworth A, Massare MJ, Cai R, Fries L, Glenn G, et al. Severe Acute Respiratory Syndrome Coronavirus 2 Receptor (Human Angiotensin-Converting Enzyme 2) Binding Inhibition Assay: A Rapid, High-Throughput Assay Useful for Vaccine Immunogenicity Evaluation. Microorganisms. 2023; 11(2):368. https://doi.org/10.3390/microorganisms11020368

Plested, Joyce S., Mingzhu Zhu, Shane Cloney-Clark, Edmond Massuda, Urvashi Patel, Andrew Klindworth, Michael J. Massare, Rongman Cai, Louis Fries, Greg Glenn, and et al. 2023. "Severe Acute Respiratory Syndrome Coronavirus 2 Receptor (Human Angiotensin-Converting Enzyme 2) Binding Inhibition Assay: A Rapid, High-Throughput Assay Useful for Vaccine Immunogenicity Evaluation" Microorganisms 11, no. 2: 368. https://doi.org/10.3390/microorganisms11020368

Plested, J. S., Zhu, M., Cloney-Clark, S., Massuda, E., Patel, U., Klindworth, A., Massare, M. J., Cai, R., Fries, L., Glenn, G., & Kalkeri, R. (2023). Severe Acute Respiratory Syndrome Coronavirus 2 Receptor (Human Angiotensin-Converting Enzyme 2) Binding Inhibition Assay: A Rapid, High-Throughput Assay Useful for Vaccine Immunogenicity Evaluation. Microorganisms, 11(2), 368. https://doi.org/10.3390/microorganisms11020368